Michael Mollnitz
Strategy Director | Portfolio & Projects | Medical Devices | Pharma at Novo Nordisk | Copenhagen Metropolitan Area, Denmark
Michael Mollnitz’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Strategy Director | Portfolio & Projects | Medical Devices | Pharma at Novo Nordisk in March 2023 - Present
Marketing Director | WIDEX | Portfolio Strategy | Launch Planning | Medical Device at WSAudiology in March 2022 - February 2023
Marketing Director | Portfolio Management Office | Merger | Product Strategy | Medical Device at WSAudiology in May 2019 - February 2022
Head of New Product Planning | WIDEX | Innovation | Medical Devices at WSA – Wonderful Sound for All in October 2016 - April 2019
Business Development Manager | Strategy Deployment | Channel & category Optimization at Carlsberg Group in February 2016 - September 2016
Marketing Manager | LEGO Speed Champions at The LEGO Group in February 2014 - January 2016
Marketing Manager | LEGO Jurassic World at The LEGO Group in February 2014 - January 2016
Marketing Manager | LEGO Pirates at LEGO Group in September 2013 - January 2016
Associate Marketing Manager | LEGO Legends of Chima at LEGO Group in September 2012 - August 2013
Graduate | Sales & Marketing at LEGO Group in September 2010 - August 2012
Junior Consultant | Application Innovation Services/General Business at IBM in September 2009 - August 2010
Master Thesis Student at Vestas Wind Systems A/S in January 2010 - July 2010
Junior Analyst | Marketing Performance at IBM in September 2008 - August 2009
Bachelor Thesis Student at Future Lab Business Consulting in February 2008 - June 2008
Category Manager at SuperBest in July 2003 - January 2004
Area Manager at McDonald's Corporation in December 2001 - June 2003
Area Manager at SuperBest in December 1999 - November 2001
Copenhagen Business School, Master of Science (MSc), July 2026
MiniMBA, Master of Business Administration - MBA, July 2026
Bond University, Bachelor of Science (BSc), July 2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Michael Mollnitz email address?
Email Michael Mollnitz at [email protected] and [email protected]. This email is the most updated Michael Mollnitz's email found in 2026.
What is Michael Mollnitz phone number?
Michael Mollnitz phone number is +4520605002.
How to contact Michael Mollnitz?
To contact Michael Mollnitz send an email to [email protected] or [email protected]. If you want to call Michael Mollnitz try calling on +4520605002. (updated on April 28, 2026)
What company does Michael Mollnitz work for?
Michael Mollnitz works for Novo Nordisk.
What is Michael Mollnitz's role at Novo Nordisk?
Michael Mollnitz is Strategy Director | Portfolio & Projects | Medical Devices | Pharma
What industry does Michael Mollnitz work in?
Michael Mollnitz works in the Medical Devices industry.
